{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:09:52Z","timestamp":1780384192566,"version":"3.54.1"},"reference-count":19,"publisher":"The Endocrine Society","issue":"6","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007155","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W015455\/1"],"award-info":[{"award-number":["MR\/W015455\/1"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007155","name":"Medical Research Council","doi-asserted-by":"publisher","award":["1004412"],"award-info":[{"award-number":["1004412"]}],"id":[{"id":"10.13039\/501100007155","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mild autonomous cortisol secretion (MACS) has an increasing prevalence with age and is associated with cardiometabolic comorbidity and increased mortality. Current guidelines recommend the majority of patients with MACS be managed conservatively, with select people referred for laparoscopic adrenalectomy. There are currently no licensed medications for MACS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to systematically review the literature to map out the current available evidence on the use of medical therapy in the treatment of MACS and to assess the research gap. Additionally, we sought to establish the outcome measurements used, to inform the design of future prospective clinical trials.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>We searched MEDLINE and EMBASE from conception as well as clinical trial registries to detect all original studies of medical treatments in MACS. Titles and abstracts were screened and full articles reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 5369 results were found from the search strategy. Thirteen studies met the inclusion criteria, of which 8 were conference abstracts and 5 full-text studies were included in the final analysis. This included 2 studies of metyrapone and 3 studies that used mifepristone. Common outcome measures included blood pressure, glucose measurements, weight, and side effect data.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>There is a considerable knowledge gap with regard to the medical management of MACS. Current available evidence consists of a handful of small, heterogeneous studies with a suggestion of a potential benefit in initiating mifepristone or metyrapone in this cohort. Our results highlight the urgent need for larger, prospective studies. To support this, we have provided suggestions for outcome measures.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jendso\/bvag090","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:57:40Z","timestamp":1775649460000},"source":"Crossref","is-referenced-by-count":0,"title":["Medical therapy in mild autonomous cortisol secretion"],"prefix":"10.1210","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3959-5112","authenticated-orcid":false,"given":"Alan","family":"Kelsall","sequence":"first","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield , Sheffield S10 2RX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Agboola","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield , Sheffield S10 2RX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evie","family":"Bryden","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield , Sheffield S10 2RX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Healey","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield , Sheffield S10 2RX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Tolhurst","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield , Sheffield S10 2RX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Hind","sequence":"additional","affiliation":[{"name":"School of Health, University of Leeds , Leeds LS2 9JT ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0835-5493","authenticated-orcid":false,"given":"John","family":"Newell-Price","sequence":"additional","affiliation":[{"name":"School of Medicine and Population Health, University of Sheffield , Sheffield S10 2RX ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"issue":"1","key":"2026060202461262900_bvag090-B1","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2026060202461262900_bvag090-B2","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","article-title":"Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis","volume":"189","author":"Pelsma","year":"2023","journal-title":"Eur J Endocrinol"},{"issue":"7","key":"2026060202461262900_bvag090-B3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2026060202461262900_bvag090-B4","volume-title":"Protocol for Systematic Scoping Review Medical Interventions for Mild Autonomous Cortisol Excess (MACS)","author":"Kelsall","year":"2024"},{"issue":"7","key":"2026060202461262900_bvag090-B5","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"issue":"10","key":"2026060202461262900_bvag090-B6","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth"},{"key":"2026060202461262900_bvag090-B7","doi-asserted-by":"publisher","author":"Kelsall","DOI":"10.15131\/shef.data.31821475"},{"issue":"4","key":"2026060202461262900_bvag090-B8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060984","article-title":"Mifepristone reduces insulin resistance in patient volunteers with adrenal incidentalomas that secrete low levels of cortisol: a pilot study","volume":"8","author":"Debono","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"2026060202461262900_bvag090-B9","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1210\/jc.2017-00823","article-title":"Resetting the abnormal circadian cortisol rhythm in adrenal incidentaloma patients with mild autonomous cortisol secretion","volume":"102","author":"Debono","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2026060202461262900_bvag090-B10","article-title":"Effects of mifepristone on nonalcoholic fatty liver disease in a patient with a cortisol-secreting adrenal adenoma","volume":"2017","author":"Ragucci","year":"2017","journal-title":"Case Rep Endocrinol"},{"issue":"8","key":"2026060202461262900_bvag090-B11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.4158\/EP-2019-0047","article-title":"Mifepristone treatment for mild autonomous cortisol secretion due to adrenal adenomas: a pilot study","volume":"25","author":"Belokovskaya","year":"2019","journal-title":"Endocr Pract"},{"issue":"3","key":"2026060202461262900_bvag090-B12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/cen.70056","article-title":"Efficacy and tolerability of metyrapone in mild autonomous cortisol secretion: real-world findings from clinical practice","volume":"104","author":"Berry","year":"2025","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"10","key":"2026060202461262900_bvag090-B13","doi-asserted-by":"crossref","first-page":"e3865","DOI":"10.1210\/clinem\/dgab450","article-title":"An open-label phase I\/IIa clinical trial of 11\u03b2-HSD1 inhibitor for Cushing's syndrome and autonomous cortisol secretion","volume":"106","author":"Oda","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2026060202461262900_bvag090-B14","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2337\/dc25-1055","article-title":"Inadequately controlled type 2 diabetes and hypercortisolism: improved glycemia with mifepristone treatment","volume":"48","author":"DeFronzo","year":"2025","journal-title":"Diabetes Care"},{"issue":"5","key":"2026060202461262900_bvag090-B15","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/ejendo\/lvaf216","article-title":"Effects of metyrapone in patients with mild hypercortisolism","volume":"193","author":"Musolino","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"6","key":"2026060202461262900_bvag090-B16","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/SLA.0000000000006183","article-title":"Adrenalectomy improves body weight, glucose, and blood pressure control in patients with mild autonomous cortisol secretion: results of an randomized controlled trial by the co-work of adrenal research (COAR) study","volume":"279","author":"Koh","year":"2024","journal-title":"Ann Surg"},{"issue":"7","key":"2026060202461262900_bvag090-B17","doi-asserted-by":"crossref","DOI":"10.1530\/EC-25-0361","article-title":"Randomized trial studying metabolic outcomes and quality of life after adrenalectomy versus conservative management for mild autonomous cortisol secretion","volume":"14","author":"Ueland","year":"2025","journal-title":"Endocr Connect"},{"key":"2026060202461262900_bvag090-B18","author":"Office for National Statistics (ONS)","year":"2024"},{"issue":"6","key":"2026060202461262900_bvag090-B19","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/ejendo\/lvae157","article-title":"Cognition in patients with mild autonomous cortisol secretion at baseline and post-adrenalectomy","volume":"191","author":"Saini","year":"2024","journal-title":"Eur J Endocrinol"}],"container-title":["Journal of the Endocrine Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jes\/advance-article-pdf\/doi\/10.1210\/jendso\/bvag090\/68021425\/bvag090.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/6\/bvag090\/68021425\/bvag090.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jes\/article-pdf\/10\/6\/bvag090\/68021425\/bvag090.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T06:46:21Z","timestamp":1780382781000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jes\/article\/doi\/10.1210\/jendso\/bvag090\/8650808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5,6]]}},"URL":"https:\/\/doi.org\/10.1210\/jendso\/bvag090","relation":{},"ISSN":["2472-1972"],"issn-type":[{"value":"2472-1972","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,4,9]]},"article-number":"bvag090"}}